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Since the discovery of the ob gene (Zhang et al. 1994) , much research has focused on its product leptin and its role in energy balance and metabolism (Campfield et al. 1996; Car0 et al. 1996; Trayhum, 1996 Lonnqvist & Schalling, 1997) .
The leptin gene is expressed in white adipose tissue (WAT; and brown adipose tissue (BAT)) under conditions when high energy surplus leads to triacylglycerol accumulation (Zhang et al. 1994; Trayhum, 1996) . Such conditions include obesity, feeding, increased glucose and insulin concentrations, and also administration of cytokines and endotoxins. Conversely, leptin expression is decreased by weight reduction, fasting, cold exposure and Pyreceptor agonists, thiazolidinediones, and in insulin-dependent diabetes (Lonnqvist & Schalling, 1997) . Leptin administration to ob/ob mice reduces appetite, increases metabolic rate and decreases fat mass (Pelleymounter et al. 1995; Hwa et al. 1997) .
Leptin has been shown to act centrally both to suppress appetite and increase energy metabolism (Halaas et al. 1995; Pelleymounter et al. 1995) . Leptin receptors in the hypothalamus (Tartaglia et al. 1995) have been shown to mediate the satiety effects by depressing neuropeptide Y production Stephens et al. 1995) and increase metabolism by activation of the efferent sympathetic system (Campfield et al. 1996) .
More recently, it has been found that leptin has direct peripheral effects on metabolism. Receptors for leptin are found on the cell surface of many tissues (Caro et al. 1996) and leptin has been shown to stimulate metabolism in cultured cells (Pallett et al. 1997; Shimabukuro et al. 1997b ) and isolated tissues (Liu et al. 1997) , particularly by intracellular lipolysis and fatty acid oxidation .
Clearly, leptin can affect whole-body fat energy storage by influencing both sides of the energy balance equation, either input (feeding) and/or output (metabolism), whichever is appropriate to biological circumstances (Caro et al. 1996) . Thus, leptin satisfies the signal postulated by Kennedy (1953) in his lipostatic hypothesis.
The present review discusses the role of proton leak in general in whole-body metabolism and in the regulation of energy balance. It examines evidence for the role of leptin in controlling metabolism, and discusses the different leak mechanisms by which leptin may potentially affect the efficiency of oxidative phosphorylation.
It is first necessary to give some background in bioenergetics to enable an understanding of the leak mechanisms and their role.
Oxidative phosphorylation
A convenient and accurate measure of resting whole-body metabolism in mammals can be achieved by using indirect calorimetry to measure 0 2 consumption and C02 production rates (Blaxter, 1989) . The main site of 0 2 consumption and C02 production is the mitochondrion, where ATP synthesis is coupled to 0 2 consumption by a process termed oxidative phosphorylation (Nicholls & Ferguson, 1992) . This process is best described by the chemiosmotic theory of Mitchell (1961) . Reducing equivalents such as NADH2 and FADH2, derived from the oxidation of reduced C compounds (the carbohydrate or fatty acid molecules derived directly from the diet or released from the fuel stores of the body), feed electrons into the electron transport chain. This chain is situated in the mitochondrial inner membrane. As electrons pass down the chain, protons are translocated across the mitochondrial inner membrane from the matrix space to the inter-membrane space, thus setting up a delocalized trans-membrane proton electrochemical gradient (Ap). Ap can drive useful work such as (1) metabolite transport across the inner membrane (e.g. ADP-ATP exchange and phosphate/proton symport) and (2) ATP synthesis from matrix ADP and phosphate by driving protons through the ATP synthase which is also located in the inner membrane and extends into the matrix. Hence, ATP synthesis is coupled to 0 2 consumption via the electrochemical gradient. This is the principal source of ATP at rest. However, it has long been known from H+/O stoichiometric studies of the electron transport chain and H+/ATP stoichiometric studies of the ATP synthase, that ATP synthesis is not perfectly coupled to 0 2 consumption in intact mitochondria (Brand, 1977) . The reason for this discrepancy is that the mitochondrial inner membrane is not absolutely impermeable to protons, i.e. there is an inefficiency in the system, namely a leakage of protons across the mitochondrial inner membrane.
Leakage of protons across the mitochondrial inner membrane: 'proton leak'
A quantitatively very important mechanism contributing to whole-body metabolism is diffusion-mediated 'proton leak' (Brand, 1990 ). This 'proton leak' is thought to be a nonenzymic diffusion process that occurs across the inner membrane of all mitochondria and displays a non-linear dependence on its driving force, the Ap, such that the leak is maximal when mitochondria are not making ATP and minimal when they are (Nicholls & Rial, 1974; Brown & Brand, 1986; Rolfe et ul. 1994; Nicholls, 1997) . Diffusion of other ions shows a similar kinetic profile (Brown & Brand, 1986) . The mechanism of this leak is not fully understood. Under certain conditions studied, there is a correlation between 'proton leak' and inner membrane surface area (Porter et al. 1996) , as one would expect for a diffusion process. In addition, 'proton leak' can be measured directly through liposomes (Brookes et al. 1997a,b) . However, the role played by inner membrane composition on differences in 'proton leak' rate is still unclear (Brown &Brand, 1991; Porter etal. 1996; Brookes et al. 1997a,b) . 'Proton leak' can be measured indirectly by measuring the rate of 0 2 consumption by mitochondria in the presence of saturating amounts of oligomycin, which prevents any ATP synthesis by proton flux through ATP synthase. 'Proton leak' is found in mitochondria from all tissues studied so far: liver, thymus, lymphocytes, skeletal muscle, heart and even BAT mitochondria (Nicholls & Rial, 1974; Brand et al. 1994; Rolfe & Brand, 1997) . Furthermore, 'proton leak' is not just observable in isolated mitochondria. A similar non-ohmic dependence of 0 2 consumption on Ap is observed for nonphosphorylating mitochondria in situ in a variety of cells (hepatocytes, thymocytes and lymphocytes) and tissue (skeletal muscle; Rolfe & Brand, 1996a) . In fact, 'proton leak' accounts for approximately 20 % of the resting 0 2 consumption of cells, and up to approximately 30 % of the resting 0 2 consumption of rat hindquarter skeletal muscle. Indeed, 'proton leak' is a significant contributor to resting 0 2 consumption in the whole animal and per se must be important in the energy budget (Rolfe & Brand, 1996b) .
Apart from being quantitatively important, 'proton leak' seems to vary in accordance with factors that determine standard metabolic rate, such as body mass, thyroid status and phylogeny (Brand et ul. 1994; Rolfe & Brown, 1997) . It has clearly been demonstrated that smaller mammals, which have a greater mass-specific metabolic rate than larger mammals, have greater (liver) mitochondrial 'proton leak' rates (Porter & Brand, 1993 , 1995a . Rats made hyperthyroid have higher liver mitochondrial 'proton leak' rates when compared with their euthyroid controls (Hafner et al. 1988; , 1994 ), and vice versa; rats made hypothyroid have lower 'proton leak' rates. Also bearded dragon lizards (Amphibolurus vitticeps) of equivalent mass to rats have lower whole-body resting metabolic rates and lower 'proton leak' rates . This area has been reviewed recently (Rolfe & Brand, 1997; Rolfe & Brown, 1997) .
Obese (ob/ob) mice, which lack functional leptin, have been shown to have increased 'proton leak' in experiments on isolated liver mitochondria compared with mitochondria from lean controls , although liver mitochondrial 'proton leak' was not increased in fa/fa rats compared with their littermate controls (RK Porter, JA Buckingham and MD Brand, unpublished results) . A high dose of leptin once daily for 2-3 d restores the kinetic leak profile of ob/ob mice to that of lean controls (Melia et al. 1997 ). The result is consistent with the general 'normalization' effects observed when leptin is administered to ob/ob mice (Car0 etal. 1996) .
Leakage of protons across the mitochondrial inner membrane: uncoupling proteins
In addition to diffusion-mediated 'proton leak', it is widely known that the inner mitochondrial membrane of the brown adipocyte contains an uncoupling protein (UCP; originally called thermogenin) enabling dissipation of the protein gradient independently of ATP utilization, thus enabling fuel to be oxidized for direct production of heat in thermoregulation (and, at least in rodents, also for energy regulatory thermogenesis; Nicholls & Locke, 1984) . Recent research has shown that there is a family of UCP occurring in BAT and other tissues, which has necessitated the renaming of the classic UCP of BAT to UCPl . As a consequence of its relatively early discovery (Nicholls et al. 1978; Ricquier & Kader, 1978) there is a lot of information on the mechanism and regulation of UCPl activity. UCPl is a 32 kDa protein incorporated into the mitochondrial inner membrane to form a 'proton conductance channel', as a result of sympathetic nervous system action via novel P3-adrenergic receptors on the surface of BAT cells (Rohlfs et al. 1995) . Noradrenaline release as a result of cold exposure increases UCPl expression in BAT. Active BAT is the principal site of non-shivering thennogenesis, and although it accounts for approximately 1% of the body mass of a rat (Foster, 1986) , it accounts for 50 % of the heat production in non-shivering thermogenesis, at least in the coldacclimated rat (Foster & Frydman, 1979) . Diet, in particular a high-carbohydrate cafeteria diet, can also induce UCPl expression in BAT of rodents (Rothwell & Stock, 1986) . BAT UCPl activity is also modulated by thyroid hormone (Silva & Rabelo, 1997) . Recent studies on cultured human pre-adipocytes show a marked increase in UCPl in response to peroxisomal proIiferating activator receptor agonist, troglitazone (Paulik & Lenhard, 1997; Digby et al. 1998 ). Retinoic acid also increases UCPl expression in mice in vivo and in vitro (Puigserver et al. 1996) . UCPl is predicted to have six trans-membrane helices and has three amino acid motifs common to all mitochondrial inner membrane transporters cloned so far (Klaus et al. 1991; Palmieri, 1994) . The in vitro binding of GDP to a purine-nucleotide binding site of UCPl, located on the cytosolic side in isolated mitochondria, prevents proton conductance through UCPl (Nicholls & Rial, 1974) . UCPl activity has also been shown to be regulated by free fatty acids which promote its proton conductance activity (Nicholls & Rial, 1974) . There is also evidence that UCPl is a chloride channel.
In fully active BAT, where extensive uncoupling protein resides within the inner membrane of mitochrondria in that tissue, only small Ap values are obtainable, and 0 2 https://doi.org/10.1079/PNS19980065 Downloaded from https://www.cambridge.org/core. IP address: 54.70.40.11, on 11 Dec 2019 at 19:04:48, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. consumption is essentially uncoupled from ATP synthesis. The leak rate of protons across the inner membrane of mitochondria isolated from active BAT displays a linear dependence on Ap (Nicholls, 1974; Nicholls & Rial, 1974) . Little information exists about the effect of leptin on BAT activity; however, leptin administration has been shown to increase noradrenaline turnover in interscapular BAT, increase BAT mass and increase UCPl expression in BAT in normal rats (Collins et al. 1996; Scarpace et al. 1997) .
The existence of other UCP only came to light recently (Boss et al. 19973; Fleury et al. 1997; Vidal-Puig et al. 1997) . UCP2 was cloned using primers to UCPl and was found to be widespread in mammalian tissues, with highest levels being found in WAT, BAT, heart, spleen, thymus, macrophages, bone marrow and stomach. In the liver, UCP2 is present only in Kupffer cells, not the hepatocytes themselves ). UCP2 has an approximate molecular mass of 30 kDa and has approximately 56 % homology to UCPl in rats .
A third UCP (UCP3) has also been cloned. It has two isoforms: a long form (UCP~L) and a short form (UCP3s; Boss et al. 1997b; Vidal-Puig et al. 1997) . The short form has 275 amino acid residues and the long form has an additional thirty-seven residues. The two human isoforms have amino acid homologies of 57 and 73 % to UCPl and UCP2 respectively. UCP3s lacks the sixth potential trans-membrane region and the putative nucleotide binding site. Expression of UCP3 is most abundant in skeletal muscle and BAT (Boss et al. 19976) . Like UCP1, UCP2 and UCP3 expression is increased in BAT on cold exposure of rodents (Boss et al. 1997~; Larkin et al. 1997; Vidal-Puig et al. 1997 ; for a contradictory view on UCP3, see Boss et al. 1998 ). It has also been shown that in UCP1-knockout mice, UCP2 expression is dramatically increased on cold exposure (Enerback et al. 1997 ). In addition, like UCPl, P3-agonists increase expression of UCP3 but have not been found to affect UCP2 expression (Gong et al. 1997) . Thyroid hormone has been shown to modulate UCP2 expression in WAT, heart and skeletal muscle, and UCP3 expression in skeletal muscle and BAT (Gong et al. 1997; Lanni et al. 1997; Larkin et al. 1997; Masaki et a/. 1997) . High-fat diet, 48 h starvation and dexamethasone increase UCP3 expression in skeletal muscle but decrease UCP3 expression in BAT (Matsuda et al. 1997) . High-fat diets increase UCP2 expression in WAT and the peroxisomal proliferating activator receptor agonist troglitazone (a thiazolidinedione) has been shown to increase UCP2 expression in pancreatic islet cells, adipocytes and pre-adipocytes (Aubert et al. 1997; Matsuda et al. 1997; . Fasting has been shown to increase UCP2 and UCP3 expression in human subjects (Millet et al. 1997; Boss et al. 1998) . UCP2 and UCP3 have been mapped to adjacent genes on chromosome 1 lq13 in human subjects, close to markers of resting metabolic rate (Bouchard et a/. 1997; Solanes et al. 1997) . Again, information about the role played by leptin in the activity of these novel UCP is limited. Suffice it to say, in normal rats over-expression of leptin increased UCP2 expression in both islet cells and in WAT (particularly epididymal, retroperitoneal and subcutaneous depots; Zhou et al. 1997) . Leptin increased UCP3 expression in muscle and BAT in ob/ob mice (Gong et al. 1997) .
There is no doubt that the extent of the evidence for a physiological role for these novel UCP has to date been rather limited. It has been demonstrated that yeast cells ) and myoblasts (Boss et al. 1998 ) transfected with UCP have decreased mitochondrial membrane potential and, as described previously, factors that regulate metabolism have been shown to affect UCP expression (as detected by Northern blot analysis). It is also possible that the diffusion-mediated 'proton leak' measured in different tissues Rolfe & Brand, 1997 ) may be due, in part, to the presence of submaximal amounts of UCP in those tissues (with the possible exception of liver parenchyma cells, where no UCP have been shown to be expressed; . Clearly now, the differential role played by UCP in physiology, medicine and energy metabolism requires a concerted multidisciplinary investigation.
Leptin effects on mitochondria1 'proton leak' and uncoupling proteins: implications for mammalian energy metabolism
Mitochondria1 'proton leak' has been demonstrated to be an important mechanism by which basal metabolism is determined (Rolfe & Brand, 1997) . It has been shown that 'proton leak' in liver mitochondria is greater in ob/ob mice compared with lean mice, and that a short course of leptin administration (without significant changes in body mass) normalizes the 'proton leak' of ob/ob mice to that of controls. Clearly, constitutive leptin production plays a role in determining metabolic homeostasis. The increased expression of UCP in rodents as a result of leptin administration is consistent with the increased metabolic rates observed for these animals when leptin is administered (Pelleymounter et a/. 1995) . Although the liver is quantitatively important when accounting for basal metabolism in mammals (20 % of the basal metabolism of a rat; Rolfe & Brand, 1997) , the increased BMR in the whole animal most probably reflects the increase in UCP expression and activity within mitochondria of muscle, BAT and other highly-metabolic visceral organs.
And finally, leptin levels and UCP activity may have roles in determining insulin resistance and insulin sensitivity of islets cells Zhou et al. 1997) . The observations that leptin promotes intracellular triacylglycerol oxidation and increases UCP2 expression in islet cells have implications for lipotoxicity, which is postulated to be the basis of islet insulin resistance and insulin insensitivity.
Clearly, knowledge of the role of leptin in determining the efficiency of mitochondrial oxidative phosphorylation via 'proton leak'/UCP expression has implications for our understanding of basic physiology, but also has clinical implications in terms of anti-obesity and anti-diabetic strategies.
